Replies to post #116746 on Biotech Values

[DewDiligence]

All I can think of is how dumb MEDX board was to sell out for $2.1B!

They might have been dumb, but I don’t think it’s fair to say this just because Ipi succeeded in melanoma. This was a relatively high-risk program even within the confines of oncology.

[BTH]

sell out for $2.1B!

The Board was probably paranoid and scared to death having been talked into the "double dip" "depression" scare tactics from their investment bankers, coming off the heels of the 2008 stock market debacle.